Flumezapine and zotepine: 5-hydroxytryptamine antagonism not involved in the lack of synergism of these antipsychotic drugs with amfonelic acid in rats

J Pharm Pharmacol. 1985 Oct;37(10):755-6. doi: 10.1111/j.2042-7158.1985.tb04961.x.

Abstract

Two antipsychotic drugs, flumezapine and zotepine, resembled clozapine, not spiperone, in not acting synergistically with amfonelic acid to elevate striatal concentrations of 3,4-dihydroxyphenylacetic acid (DOPAC) in rats. Since flumezapine, zotepine and clozapine antagonize 5-hydroxytryptamine (5-HT) receptors with potency similar to their potency in antagonizing dopamine receptors, the possibility that 5-HT receptor blockade prevented their synergism with amfonelic acid was considered. Methiothepin, a potent 5-HT antagonist and dopamine antagonist, mimicked spiperone in causing a marked increase in striatal DOPAC in amfonelic acid-treated rats, indicating that 5-HT antagonism is not involved in the lack of synergism of flumezapine and zotepine with amfonelic acid.

MeSH terms

  • 3,4-Dihydroxyphenylacetic Acid / metabolism
  • Animals
  • Anti-Anxiety Agents / pharmacology*
  • Antipsychotic Agents / pharmacology*
  • Benzodiazepines / pharmacology*
  • Corpus Striatum / metabolism
  • Dibenzothiepins / pharmacology*
  • Drug Synergism
  • Male
  • Nalidixic Acid / analogs & derivatives
  • Naphthyridines / pharmacology*
  • Rats
  • Rats, Inbred Strains
  • Serotonin Antagonists / pharmacology*

Substances

  • Anti-Anxiety Agents
  • Antipsychotic Agents
  • Dibenzothiepins
  • Naphthyridines
  • Serotonin Antagonists
  • 3,4-Dihydroxyphenylacetic Acid
  • Benzodiazepines
  • Nalidixic Acid
  • flumezapine
  • amfonelic acid
  • zotepine